Crossmark

Targeting the NLRP3 by Natural Compounds: Therapeutic Strategies to Mitigate Doxorubicin-Induced Cardiotoxicity

Crossref DOI link: https://doi.org/10.1007/s12013-025-01723-4

Published Online: 2025-03-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shackebaei, Dareuosh https://orcid.org/0000-0002-5919-9750
Yari, Kheirollah https://orcid.org/0000-0002-8592-7651
Rahimi, Nader https://orcid.org/0000-0002-9328-1408
Gorgani, Sara https://orcid.org/0000-0002-6710-8089
Yarmohammadi, Fatemeh https://orcid.org/0000-0002-0552-8766
License Information

Text and Data Mining valid from 2025-03-18

Version of Record valid from 2025-03-18
More Information

Article History

Accepted: 8 March 2025

First Online: 18 March 2025

Compliance with ethical standards

:

: The authors declare no competing interest.